Journals / Türk Kardiyoloji Derneği Arşivi / 2018 / Cilt: 46 - Sayı: 1

Clinical characteristics and outcomes of acute coronary syndrome patients with intra-aortic balloon pump inserted in intensive cardiac care unit of a tertiary clinic

Tersiyer bir kliniğin ileri kardiyak bakım ünitesinde intra-aortik balon pompası takılan akut koroner sendromlu hastaların klinik özellikleri ve sonlanımları

Pages
10–17
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Patientswho are identified as having a greater risk of mortality according to admission parameters should be further treated withother mechanical circulatory support devices.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: An intra-aortic balloon pump (IABP) is a mechanical support device that is used in addition to pharmacological treatment of the failing heart in intensive cardiac care unit(ICCU) patients.
📊
Key Findings & Data:This study is an analysis of the clinical characteristics and outcomes of these acutecoronary syndrome patients.Methods: The data of patients who were admitted to theICCU between September 2014 and March 2017 were analyzed retrospectively.
💡
Conclusion & Impact:Patientswho are identified as having a greater risk of mortality according to admission parameters should be further treated withother mechanical circulatory support devices.
🔬Design:Research Article
📍Scope:2014 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: An intra-aortic balloon pump (IABP) is a mechanical support device that is used in addition to pharmacological treatment of the failing heart in intensive cardiac care unit(ICCU) patients. In the literature, there are limited data regarding the clinical characteristics and in-hospital outcomesof acute coronary syndrome patients in Turkey who had anIABP inserted during their ICCU stay. This study is an analysis of the clinical characteristics and outcomes of these acutecoronary syndrome patients.Methods: The data of patients who were admitted to theICCU between September 2014 and March 2017 were analyzed retrospectively. The data were retrieved from the ICCUelectronic database of the clinic. A total of 142 patients treatedwith IABP were evaluated in the study. All of the patients werein cardiogenic shock following percutaneous coronary intervention, at the time of IABP insertion.Results: The mean age of the patients was 63.0±9.7 yearsand 66.2% were male. In-hospital mortality rate of the studypopulation was 54.9%. The patients were divided into 2 groups,consisting of survivors and non-survivors of their hospitalization period. Multivariate analysis after adjustment for the parameters in univariate analysis revealed that ejection fraction,Thrombolysis in Myocardial Infarction flow score of ≤2 after theintervention, chronic renal failure, and serum lactate and glucose levels were independent predictors of in-hospital mortality.Conclusion: The mortality rate remains high despite IABPsupport in patients with acute coronary syndrome. Patientswho are identified as having a greater risk of mortality according to admission parameters should be further treated withother mechanical circulatory support devices.

Özet

Amaç: İntraaortik balon pompasının (İABP) kardiyak yoğun bakım ünitesi (KYBÜ) hastalarındaki kalp pompa yetersizliğinde farmakolojik tedaviye ek destek tedavisi olarak kullanılması kabul görmüş bir uygulamadır. Kardiyak yoğun bakım ünitesine kabul edilen İABP takılmış akut koroner sendromlu hastaların klinik özellikleri ve hastane içi sonuçları hakkında literatürde ülkemiz hakkında sınırlı veri vardır. Çalışmamızda bu akut koroner sendromlu hastaların klinik özelliklerini ve sonuçlarını incelemeyi amaçladık. Yöntemler: Eylül 2014 ile Mart 2017 arasında KYBÜ’ye kabul edilen hastaların verileri geriye dönük olarak incelendi. Veriler kliniğimizin KYBÜ elektronik veri tabanından elde edildi. İntraaortik balon pompası takılan 142 hasta çalışmamızda değerlendirildi. Perkütan koroner girişimi takiben, tüm hastalar İABP takılması sırasında kardiyojenik şoktaydı. Bulgular: Hastaların ortalama yaşı 63.0±9.7 idi ve %66.2’si erkekti. Çalışma grubunun hastane içi mortalitesi %54.9 idi. Hastalar hastanedeki içi mortalitelerine göre hayatta kalanlar ve hayatını kaybedenler olmak üzere ikiye ayrıldı. Tek değişkenli analizdeki parametrelerin kullanımı ile yapılan çok değişkenli analizde ejeksiyon fraksiyonu, perkütan girişim sonrasında TIMI ≤2 akım olması, kronik böbrek yetersizliği, serum laktat ve glukoz düzeyleri hastane içi mortalitenin bağımsız öngördürücüleri olarak saptandı. Sonuç: Akut koroner sendromlu hastalarda İABP desteğine rağmen mortalite yüksektir. Başvuru parametrelerine göre mortalite bakımından yüksek riskli olarak belirlenmiş hastalar diğer mekanik destek cihazları ile tedavi edilmelidir.

🔖

Cite This Article

Çanga, Y., Hayıroğlu, M. İ., Pehlivanoğlu, S., Acarel, M., Kalenderoğlu, K., Uzun, A. O., Keskin, M., Gümüşdağ, A., Çinier, G., Bozbeyoğlu, E., Yıldırımtürk, Ö. (2022). Clinical characteristics and outcomes of acute coronary syndrome patients with intra-aortic balloon pump inserted in intensive cardiac care unit of a tertiary clinic. Türk Kardiyoloji Derneği Arşivi, Cilt: 46 - Sayı: 1, 10–17. https://ajindex.com/articles/632193

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Van de Werf F, Bax J, Betriu A, Blomstrom-Lundqvist C, Crea F, Falk V, et al
  2. ESC Committee for Practice Guidelines (CPG). Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J 2008
  3. 2909–45. [CrossRef] 2. Kushner FG, Hand M, Smith SC Jr, King SB 3rd, Anderson JL, Antman EM, et al. 2009 focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update) a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2009
  4. 2205–41. 3. Thiele H, Allam B, Chatellier G, Schuler G, Lafont A. Shock in acute myocardial infarction: the Cape Horn for trials? Eur Heart J 2010
  5. 1828–35. [CrossRef] 4. Sjauw KD, Engström AE, Vis MM, van der Schaaf RJ, Baan J Jr, Koch KT, et al. A systematic review and meta-analysis of intra-aortic balloon pump therapy in ST-elevation myocardial infarction: should we change the guidelines? Eur Heart J 2009
  6. 459–68. [CrossRef] 5. Prondzinsky R, Lemm H, Swyter M, Wegener N, Unverzagt S, Carter JM, et al. Intra-aortic balloon counterpulsation in patients with acute myocardial infarction complicated by cardiogenic shock: the prospective, randomized IABP SHOCK Trial for attenuation of multiorgan dysfunction syndrome. Crit Care Med 2010
  7. 152¬–60. 6. Thiele H, Zeymer U, Neumann FJ, Ferenc M, Olbrich HG, Hausleiter J, et al
  8. IABP-SHOCK II Trial Investigators. Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med 2012
  9. 1287–96. [CrossRef] 7. O’Gara PT, Kushner FG, Ascheim DD, Casey DE Jr, Chung MK, de Lemos JA, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2013
  10. e362–425. [CrossRef] 8. Authors/Task Force members, Windecker S, Kolh P, Alfonso F, Collet JP, Cremer J, Falk V, et al. 2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association